Skip to content

Auriculotherapy for Sexual Function in Menopausal women

Auriculotherapy for Sexual Function in Climacteric women: randomized clinical trial -

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5t96cx6
Enrollment
Unknown
Registered
2025-05-14
Start date
2024-09-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Climacteric

Interventions

This is a randomized, placebo-controlled, single-blind clinical study in which only the participants will be segregated from the allocation group. The sample will be made up of women aged between 40 a
External genitalia
Internal genitalia
Hip and Master shoulder
Experimental Group Without Protocol (GEB) 5 out of 13 previously established auricular points will be chosen Sexual desire
(Ovaries. E
Ovaries.C.
Uterus.C
Uterus.E
Zero Point
Arousal Point
Shen Men
Brain
Autonomic Sympathetic
Master Oscillation
and Kidney. The five points will be chosen using the auricular palpation method and Placebo Group (GP) HandF2
HandF3

Sponsors

Universidade Federal do Ceará
Lead Sponsor
Universidade Federal do Ceará
Collaborator

Eligibility

Sex/Gender
Female
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: The study will be developed with women between 40 and 65 years old, with a score less than or equal to 23 (which indicates the presence of FSD in women in menopause) in the Female Sexual Functioning Index (FSFI) scores, followed at the aforementioned UAPS Antonina Caeté Pedrosa in Mombaça, Ceará. The following inclusion criteria will be followed for sample selection: women between 40 and 65 years old; presenting cognitive capacity to respond to the variables of interest.

Exclusion criteria

Exclusion criteria: Exclusion criteria will be: injuries or inflammation in the ear; allergy to micropore tape; pregnant women; presence of mental disorders that compromise the collection of variables of interest. The criteria for discontinuation: participants who wished to stop their participation at any time during the research; presented reactions considered unpleasant related to the treatment; disagreed with the allocation of seeds in the protocol points; missed two or more sessions for any reason.

Design outcomes

Primary

MeasureTime frame
After six auriculotherapy sessions, improvement in female sexual dysfunction determined through the Female Sexual Functioning Index is expected by at least 5% compared to pre-intervention scores

Secondary

MeasureTime frame
After six sessions of auriculotherapy, it is expected that the quality of sexual life, measured through the Female Sexual Life Quality Questionnaire, will improve by at least 5% compared to pre-intervention scores;After six sessions of auriculotherapy, an improvement in the quality of climacteric symptoms measured using the Menopause Assessment Scale is expected by at least 5% compared to pre-intervention scores

Countries

Brazil

Contacts

Public ContactJéssica Carnaúba

Universidade Federal do Ceará

jessicacarnauba91@gmail.com+55(88)8188-5159

Outcome results

None listed

Source: REBEC (via WHO ICTRP)